MediS laboratories are honoured to offer other therapeutic alternatives for the prevention and the treatment of thrombo-embolic disease.
Enoxa – sodic enoxaparine is a low molecular weight heparin presented in different dosages:
Enoxa 2000UI
Enoxa 4000UI
Enoxa 6000UI
Enoxa 8000UI
In boxes containing 2 pre-filled syringes, available in pharmacies and in hospital.
Enoxa therapeutic indications are:
Enoxa 2000UI anti-Xa/0.2ml and Enoxa 4000UI anti-Xa/0.4ml:
- Prophylactic treatment of venous thrombo-embolic disease in surgery, in high or moderate risk situations.
- Prevention of coagulation in the extra-corporal circulation circuit in course of hemodialysis.
- Prophylactic prevention of deep venous thrombosis in confined to bed patients during acute diseases: - heart failure NYHA III or IV stages
- Acute respiratory insufficiency
- Acute infection episode or rheumatologic affection associated to, at least, one other venous thrombo-embolic risk factor.
Enoxa 6000UI anti-Xa/0.6ml and Enoxa 8000UI anti-Xa/0.8ml:
- Curative treatment of constituted deep venous thrombosis.
- Treatment of unstable angina and of myocardial infarction without Q wave during acute stage and associated to aspirin.
